Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02499328
Title Study to Assess Combination of MEDI4736 With Either AZD9150 or AZD5069 in Patients With Metastatic Squamous Cell Carcinoma of Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications

oral squamous cell carcinoma

hypopharynx cancer

Advanced Solid Tumor

laryngeal squamous cell carcinoma

oropharynx cancer

head and neck squamous cell carcinoma

Therapies

AZD9150 + Durvalumab

AZD5069 + Durvalumab

Durvalumab

AZD9150

Age Groups: adult
Covered Countries USA


No variant requirements are available.